The American Heart Association requests that this document be cited as follows: Grundy SM,
Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-…

Context A triple-marker approach for chronic kidney disease (CKD) evaluation has not been
well studied. Objective To evaluate whether combining creatinine, cystatin C, and urine …

The National Kidney Foundation–Kidney Disease Outcomes Quality Initiative (NKF-KDOQI)
guideline for evaluation, classification, and stratification of chronic kidney disease (CKD) …

Ischemia-reperfusion injury is an important cause of liver damage occurring during surgical
procedures including hepatic resection and liver transplantation, and represents the main …

Reduced glomerular filtration rate defines chronic kidney disease and is associated with
cardiovascular and all-cause mortality. We conducted a meta-analysis of genome-wide …

The effects of ischemic preconditioning on rat liver integrity, as well as the implication of
nitric oxide (NO) and adenosine in this process, has been evaluated. Preconditioning before …

Although improved control of hypertension is known to attenuate progression of chronic
kidney disease (CKD), little is known about the adequacy of hypertension treatment in adults …

The recommendations listed in the present guideline are, whenever possible, evidence
based. An initial extensive evidence review, which included literature derived from research …

Background The association of hypertension and mortality is attenuated in elderly adults.
Walking speed, as a measure of frailty, may identify which elderly adults are most at risk for the …

Although cystatin C is a stronger predictor of clinical outcomes associated with CKD than
creatinine, the clinical role for cystatin C is unclear. We included 11,909 participants from the …